Clinical Trial Update: AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss [Phase 3]

View source ↗

Summary

A Phase 3 study (AMAZE 12) is evaluating the investigational drug NNC0487-0111 for helping people with obesity maintain weight loss; the trial status is NOT_YET…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• NNC0487-0111

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 3 | Status: NOT_YET_RECRUITING